Skip to main content
Review

Opioids in the United Kingdom: safety and surveillance during COVID-19.

Osborne V. Opioids in the United Kingdom: safety and surveillance during COVID-19. Curr Opin Psychiatry. 2021;34(4):357-362. doi: 10.1097/yco.0000000000000719.

Save
Print
July 7, 2021
Osborne V. Curr Opin Psychiatry. 2021;34(4):357-362.
View more articles from the same authors.

The opioid epidemic is an ongoing patient safety issue. This literature review examined the impact of the COVID-19 pandemic on opioid surveillance research in the United Kingdom. Of studies conducted during the pandemic, most explored the impact of the pandemic on access to opioids or opioid substitution therapy.

Save
Print
Cite
Citation

Osborne V. Opioids in the United Kingdom: safety and surveillance during COVID-19. Curr Opin Psychiatry. 2021;34(4):357-362. doi: 10.1097/yco.0000000000000719.

Related Resources From the Same Author(s)
Related Resources